Company Small Pharma Inc.
Equities
DMT
CA8316641072
Biotechnology & Medical Research
Business Summary
Number of employees: 13
Managers
Managers | Title | Age | Since |
---|---|---|---|
George Tziras
CEO | Chief Executive Officer | 43 | 21-04-28 |
David Steel
DFI | Director of Finance/CFO | - | 21-01-17 |
Ellen James
CTO | Chief Tech/Sci/R&D Officer | - | 16-12-31 |
Carol Routledge
CTO | Chief Tech/Sci/R&D Officer | - | 19-12-31 |
Alastair Riddell
COO | Chief Operating Officer | 74 | 22-05-24 |
Marie Layzell
BRD | Director/Board Member | 46 | 21-04-28 |
Emma Hodge
PRN | Corporate Officer/Principal | - | 20-12-31 |
Sarah Hamilton
AUD | Comptroller/Controller/Auditor | - | 22-05-31 |
Corporate Officer/Principal | - | 21-08-31 | |
Nina Kumari
PRN | Corporate Officer/Principal | - | 18-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Maier
BRD | Director/Board Member | 76 | 21-11-17 |
Michael Wolfe
BRD | Director/Board Member | 58 | 21-04-28 |
Lyne Fortin
CHM | Chairman | 64 | 21-04-28 |
George Tziras
CEO | Chief Executive Officer | 43 | 21-04-28 |
Marie Layzell
BRD | Director/Board Member | 46 | 21-04-28 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 336,012,037 | 229,656,844 ( 68.35 %) | 0 | 68.35 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+44.48% | 54.04B | |
+43.57% | 41.96B | |
-0.86% | 41.92B | |
-7.59% | 28.35B | |
+12.30% | 26.35B | |
-21.83% | 19B | |
+7.15% | 13B | |
+29.40% | 12.28B | |
+25.15% | 12.19B |